Pub Date : 2025-01-01Epub Date: 2024-09-25DOI: 10.14366/usg.24110
Jae Mo Koo, So-Young Yoo, Ji Hye Kim, Ji Eun Park, Sun-Young Baek, Tae Yeon Jeon
Purpose: This study aimed to explore the effects of both the presence and size of posterior subependymal germinal matrix hemorrhage (PS-GMH), considered a mild form of hemorrhage, on the neurodevelopmental outcomes of extremely preterm infants.
Methods: A retrospective analysis was conducted on 221 extremely preterm infants, assessing their initial and term-equivalent age (TEA) cranial ultrasound (cUS) examinations from 2016 to 2021. Infants were classified based on the presence and size (small/large) of PS-GMH. Neurodevelopmental outcomes at corrected ages of 18-24 months were analyzed in 135 infants.
Results: PS-GMH was identified in 86.9% (192/221) of the infants, with 13.5% (26/192) exhibiting large PS-GMH. Among the 135 infants who were followed up, those with PS-GMH were found to have younger gestational ages (P<0.001) and a higher incidence of maternal chorioamnionitis (P=0.016) than those without PS-GMH. Significant differences were observed in the incidence of grade II intraventricular hemorrhage (IVH) on initial cUS (P=0.003) and ventriculomegaly at TEA cUS (P=0.026) across the groups with no PS-GMH, small PS-GMH, and large PS-GMH. The large PS-GMH group exhibited a higher occurrence of grade II IVH than the small PS-GMH group (P=0.006). However, ventriculomegaly incidence did not significantly vary with PS-GMH status. Neurodevelopmental outcomes were also not significantly different across PS-GMH statuses. The adjusted odds ratios for any neurodevelopmental impairment, compared to the no PS-GMH group, were 1.70 (95% confidence interval [CI], 0.40 to 7.26; P=0.471) for all PS-GMH, 1.61 (95% CI, 0.37 to 6.93; P=0.526) for small PS-GMH, and 3.84 (95% CI, 0.62 to 24.00; P=0.150) for large PS-GMH.
Conclusion: PS-GMH was frequently observed in extremely preterm infants; however, it did not independently predict adverse neurodevelopmental outcomes.
{"title":"Posterior subependymal germinal matrix hemorrhage as a mild form of hemorrhage in extremely preterm infants: neurodevelopmental outcomes at corrected ages of 18-24 months.","authors":"Jae Mo Koo, So-Young Yoo, Ji Hye Kim, Ji Eun Park, Sun-Young Baek, Tae Yeon Jeon","doi":"10.14366/usg.24110","DOIUrl":"10.14366/usg.24110","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to explore the effects of both the presence and size of posterior subependymal germinal matrix hemorrhage (PS-GMH), considered a mild form of hemorrhage, on the neurodevelopmental outcomes of extremely preterm infants.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 221 extremely preterm infants, assessing their initial and term-equivalent age (TEA) cranial ultrasound (cUS) examinations from 2016 to 2021. Infants were classified based on the presence and size (small/large) of PS-GMH. Neurodevelopmental outcomes at corrected ages of 18-24 months were analyzed in 135 infants.</p><p><strong>Results: </strong>PS-GMH was identified in 86.9% (192/221) of the infants, with 13.5% (26/192) exhibiting large PS-GMH. Among the 135 infants who were followed up, those with PS-GMH were found to have younger gestational ages (P<0.001) and a higher incidence of maternal chorioamnionitis (P=0.016) than those without PS-GMH. Significant differences were observed in the incidence of grade II intraventricular hemorrhage (IVH) on initial cUS (P=0.003) and ventriculomegaly at TEA cUS (P=0.026) across the groups with no PS-GMH, small PS-GMH, and large PS-GMH. The large PS-GMH group exhibited a higher occurrence of grade II IVH than the small PS-GMH group (P=0.006). However, ventriculomegaly incidence did not significantly vary with PS-GMH status. Neurodevelopmental outcomes were also not significantly different across PS-GMH statuses. The adjusted odds ratios for any neurodevelopmental impairment, compared to the no PS-GMH group, were 1.70 (95% confidence interval [CI], 0.40 to 7.26; P=0.471) for all PS-GMH, 1.61 (95% CI, 0.37 to 6.93; P=0.526) for small PS-GMH, and 3.84 (95% CI, 0.62 to 24.00; P=0.150) for large PS-GMH.</p><p><strong>Conclusion: </strong>PS-GMH was frequently observed in extremely preterm infants; however, it did not independently predict adverse neurodevelopmental outcomes.</p>","PeriodicalId":54227,"journal":{"name":"Ultrasonography","volume":" ","pages":"48-61"},"PeriodicalIF":2.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11717686/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-10-16DOI: 10.14366/usg.24163
Vanessa Murad, Hyun-Jung Jang, Tae Kyoung Kim
Contrast-enhanced ultrasound (CEUS) offers a distinctive approach to liver mass diagnosis by utilizing intravenous contrast agents for enhanced visualization of vascular structures and tissue characterization. This review highlights the unique advantages of CEUS compared to computed tomography (CT) and magnetic resonance imaging (MRI), particularly focusing on the Liver Imaging Reporting and Data System framework. Key differences include CEUS's realtime imaging capability, which minimizes arterial phase mistiming and improves detection of hyperenhancing lesions, and its ability to provide detailed washout patterns. Also, CEUS's intravascular nature and lower risk of adverse reactions make it a safer alternative for patients with renal impairment or those contraindicated for CT/MRI.
{"title":"Unraveling distinctions between contrast-enhanced ultrasound and CT/MRI for liver mass diagnosis.","authors":"Vanessa Murad, Hyun-Jung Jang, Tae Kyoung Kim","doi":"10.14366/usg.24163","DOIUrl":"10.14366/usg.24163","url":null,"abstract":"<p><p>Contrast-enhanced ultrasound (CEUS) offers a distinctive approach to liver mass diagnosis by utilizing intravenous contrast agents for enhanced visualization of vascular structures and tissue characterization. This review highlights the unique advantages of CEUS compared to computed tomography (CT) and magnetic resonance imaging (MRI), particularly focusing on the Liver Imaging Reporting and Data System framework. Key differences include CEUS's realtime imaging capability, which minimizes arterial phase mistiming and improves detection of hyperenhancing lesions, and its ability to provide detailed washout patterns. Also, CEUS's intravascular nature and lower risk of adverse reactions make it a safer alternative for patients with renal impairment or those contraindicated for CT/MRI.</p>","PeriodicalId":54227,"journal":{"name":"Ultrasonography","volume":" ","pages":"19-30"},"PeriodicalIF":2.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11717683/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142741257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-10-20DOI: 10.14366/usg.24123
Luni Zhang, Rong Wu, Jing Chen, Shiyao Gu, Caixia Jia
Purpose: There is still insufficient evidence for predicting stroke risk in patients with mild carotid atherosclerotic stenosis. This study aimed to explore the association between carotid intraplaque neovascularization (IPN) in mild stenosis and ischemic stroke, using contrast-enhanced ultrasound (CEUS) imaging.
Methods: This retrospective observational study included 369 patients from July 2021 to March 2022. These patients were categorized as symptomatic or asymptomatic based on their recent history of ipsilateral ischemic stroke. Initial parameters of carotid plaques, such as IPN grading and contrast enhancement index, were assessed using B-mode ultrasonography and CEUS. The follow-up period lasted 12 months or until a newly-developed ischemic stroke occurred. Logistic regression models and Cox proportional-hazards regression models were employed to explore the associations between ultrasonic parameters and the incidence of recent and future ischemic strokes.
Results: In patients with mild stenosis, both increasing age and grade 2 carotid IPN were significant predictors of recent primary ischemic stroke. Furthermore, grade 2 carotid IPN independently predicted future ischemic strokes in both symptomatic and asymptomatic patients.
Conclusion: This study demonstrated that carotid IPN as detected by CEUS imaging holds potential as a useful non-invasive biomarker for predicting recent and future ischemic strokes in patients with mild carotid stenosis.
{"title":"The role of intraplaque neovascularization in recent and future ischemic stroke in patients with mild carotid stenosis.","authors":"Luni Zhang, Rong Wu, Jing Chen, Shiyao Gu, Caixia Jia","doi":"10.14366/usg.24123","DOIUrl":"10.14366/usg.24123","url":null,"abstract":"<p><strong>Purpose: </strong>There is still insufficient evidence for predicting stroke risk in patients with mild carotid atherosclerotic stenosis. This study aimed to explore the association between carotid intraplaque neovascularization (IPN) in mild stenosis and ischemic stroke, using contrast-enhanced ultrasound (CEUS) imaging.</p><p><strong>Methods: </strong>This retrospective observational study included 369 patients from July 2021 to March 2022. These patients were categorized as symptomatic or asymptomatic based on their recent history of ipsilateral ischemic stroke. Initial parameters of carotid plaques, such as IPN grading and contrast enhancement index, were assessed using B-mode ultrasonography and CEUS. The follow-up period lasted 12 months or until a newly-developed ischemic stroke occurred. Logistic regression models and Cox proportional-hazards regression models were employed to explore the associations between ultrasonic parameters and the incidence of recent and future ischemic strokes.</p><p><strong>Results: </strong>In patients with mild stenosis, both increasing age and grade 2 carotid IPN were significant predictors of recent primary ischemic stroke. Furthermore, grade 2 carotid IPN independently predicted future ischemic strokes in both symptomatic and asymptomatic patients.</p><p><strong>Conclusion: </strong>This study demonstrated that carotid IPN as detected by CEUS imaging holds potential as a useful non-invasive biomarker for predicting recent and future ischemic strokes in patients with mild carotid stenosis.</p>","PeriodicalId":54227,"journal":{"name":"Ultrasonography","volume":" ","pages":"62-71"},"PeriodicalIF":2.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11717680/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-09-23DOI: 10.14366/usg.24130
Jeongmin Lee, Ka Eun Kim, Myoung Kyoung Kim, Haejung Kim, Eun Sook Ko, Eun Young Ko, Boo-Kyung Han, Ji Soo Choi
Purpose: The study investigated whether incorporating magnetic resonance imaging (MRI) alongside ultrasonography (US) in the preoperative evaluation is associated with differing survival outcomes between male and female breast cancer patients in a matched analysis. Additionally, clinicopathological prognostic factors were analyzed.
Methods: Between January 2005 and December 2020, 93 male and 28,191 female patients who underwent breast surgery were screened. Exact matching analysis was conducted for age, pathologic T and N stages, and molecular subtypes. The clinicopathological characteristics and preoperative imaging methods of the matched cohorts were reviewed. Disease-free survival (DFS) and overall survival (OS) were assessed using Kaplan-Meier analysis, and Cox proportional hazards regression analysis was used to identify prognostic factors.
Results: A total of 328 breast cancer patients (61 men and 267 women) were included in the matched analysis. Male patients had worse DFS (10-year DFS, 70.6% vs. 89.2%; P=0.001) and OS (10-year OS, 64.4% vs. 96.3%; P<0.001) than female patients. The pathologic index cancer size (hazard ratio [HR], 2.013; 95% confidence interval [CI], 1.063 to 3.810; P=0.032) was associated with worse DFS, whereas there were no significant factors associated with OS. Adding MRI to US for preoperative evaluation was not associated with DFS (HR, 1.117; 95% CI, 0.223 to 5.583; P=0.893) or OS (HR, 1.529; 95% CI, 0.300 to 7.781; P=0.609) in male patients.
Conclusion: Adding breast MRI to US in the preoperative evaluation was not associated with survival outcomes in male breast cancer patients, and the pathologic index cancer size was associated with worse DFS.
目的:该研究通过配对分析,探讨在术前评估中结合磁共振成像(MRI)和超声波检查(US)是否与男性和女性乳腺癌患者不同的生存结果有关。此外,还分析了临床病理预后因素:方法:2005 年 1 月至 2020 年 12 月间,对接受乳腺手术的 93 名男性和 28191 名女性患者进行了筛查。对年龄、病理 T 期和 N 期以及分子亚型进行了精确配对分析。对匹配队列的临床病理特征和术前成像方法进行了回顾。采用 Kaplan-Meier 分析评估无病生存期(DFS)和总生存期(OS),并采用 Cox 比例危险回归分析确定预后因素:共有 328 名乳腺癌患者(61 名男性和 267 名女性)被纳入配对分析。男性患者的 DFS(10 年 DFS,70.6% vs. 89.2%;P=0.001)和 OS(10 年 OS,64.4% vs. 96.3%;P<0.001)均比女性患者差。病理指标癌症大小(危险比[HR],2.013;95% 置信区间[CI],1.063 至 3.810;P=0.032)与较差的 DFS 相关,而与 OS 无关。在男性患者中,术前评估时在 US 基础上增加 MRI 与 DFS(HR,1.117;95% CI,0.223 至 5.583;P=0.893)或 OS(HR,1.529;95% CI,0.300 至 7.781;P=0.609)无关:结论:男性乳腺癌患者术前评估时在US检查的基础上增加乳腺MRI检查与生存结果无关,病理指标癌症大小与较差的DFS有关。
{"title":"Impact of adding preoperative magnetic resonance imaging to ultrasonography on male breast cancer survival: a matched analysis with female breast cancer.","authors":"Jeongmin Lee, Ka Eun Kim, Myoung Kyoung Kim, Haejung Kim, Eun Sook Ko, Eun Young Ko, Boo-Kyung Han, Ji Soo Choi","doi":"10.14366/usg.24130","DOIUrl":"10.14366/usg.24130","url":null,"abstract":"<p><strong>Purpose: </strong>The study investigated whether incorporating magnetic resonance imaging (MRI) alongside ultrasonography (US) in the preoperative evaluation is associated with differing survival outcomes between male and female breast cancer patients in a matched analysis. Additionally, clinicopathological prognostic factors were analyzed.</p><p><strong>Methods: </strong>Between January 2005 and December 2020, 93 male and 28,191 female patients who underwent breast surgery were screened. Exact matching analysis was conducted for age, pathologic T and N stages, and molecular subtypes. The clinicopathological characteristics and preoperative imaging methods of the matched cohorts were reviewed. Disease-free survival (DFS) and overall survival (OS) were assessed using Kaplan-Meier analysis, and Cox proportional hazards regression analysis was used to identify prognostic factors.</p><p><strong>Results: </strong>A total of 328 breast cancer patients (61 men and 267 women) were included in the matched analysis. Male patients had worse DFS (10-year DFS, 70.6% vs. 89.2%; P=0.001) and OS (10-year OS, 64.4% vs. 96.3%; P<0.001) than female patients. The pathologic index cancer size (hazard ratio [HR], 2.013; 95% confidence interval [CI], 1.063 to 3.810; P=0.032) was associated with worse DFS, whereas there were no significant factors associated with OS. Adding MRI to US for preoperative evaluation was not associated with DFS (HR, 1.117; 95% CI, 0.223 to 5.583; P=0.893) or OS (HR, 1.529; 95% CI, 0.300 to 7.781; P=0.609) in male patients.</p><p><strong>Conclusion: </strong>Adding breast MRI to US in the preoperative evaluation was not associated with survival outcomes in male breast cancer patients, and the pathologic index cancer size was associated with worse DFS.</p>","PeriodicalId":54227,"journal":{"name":"Ultrasonography","volume":" ","pages":"72-82"},"PeriodicalIF":2.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11717687/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-09-27DOI: 10.14366/usg.24138
Hee Jun Park, Hyo Jeong Kang, So Yeon Kim, Seonghun Yoon, Seunghee Baek, In Hye Song, Hyeon Ji Jang, Jong Keon Jang
Purpose: This study assessed the impact of hepatic fibrosis on the diagnostic performance of the controlled attenuation parameter (CAP) in quantifying hepatic steatosis in patients with chronic hepatitis B (CHB).
Methods: CHB patients who underwent liver stiffness measurement (LSM) and CAP assessment using transient elastography before liver resection between 2019 and 2022 were retrospectively evaluated. Clinical data included body mass index (BMI) and laboratory parameters. The histologically determined hepatic fat fraction (HFF) and fibrosis stages were reviewed by pathologists blinded to clinical and radiologic data. The Pearson correlation coefficient between CAP and HFF was calculated. The diagnostic performance of CAP for significant hepatic steatosis (HFF ≥10%) was assessed using areas under the receiver operating curve (AUCs), stratified by fibrosis stages (F0-1 vs. F2-4). Factors significantly associated with CAP were determined by univariable and multivariable linear regression analyses.
Results: Among 399 CHB patients (median age 59 years; 306 men), 16.3% showed significant steatosis. HFF ranged from 0% to 60%. Of these patients, 9.8%, 19.8%, 29.3%, and 41.1% had fibrosis stages F0-1, F2, F3, and F4, respectively. CAP positively correlated with HFF (r=0.445, P<0.001). The AUC of CAP for diagnosing significant steatosis was 0.786 (95% confidence interval [CI], 0.726 to 0.845) overall, and significantly lower in F2-4 (0.772; 95% CI, 0.708 to 0.836) than in F0-1 (0.924; 95% CI, 0.835 to 1.000) (P=0.006). Multivariable analysis showed that BMI (P<0.001) and HFF (P<0.001) significantly affected CAP, whereas LSM and fibrosis stages did not.
Conclusion: CAP evaluations of significant hepatic steatosis are less reliable in CHB patients with significant or more advanced (F2-4) than with no or mild (F0-1) fibrosis.
{"title":"Effects of hepatic fibrosis on the quantification of hepatic steatosis using the controlled attenuation parameter in patients with chronic hepatitis B.","authors":"Hee Jun Park, Hyo Jeong Kang, So Yeon Kim, Seonghun Yoon, Seunghee Baek, In Hye Song, Hyeon Ji Jang, Jong Keon Jang","doi":"10.14366/usg.24138","DOIUrl":"10.14366/usg.24138","url":null,"abstract":"<p><strong>Purpose: </strong>This study assessed the impact of hepatic fibrosis on the diagnostic performance of the controlled attenuation parameter (CAP) in quantifying hepatic steatosis in patients with chronic hepatitis B (CHB).</p><p><strong>Methods: </strong>CHB patients who underwent liver stiffness measurement (LSM) and CAP assessment using transient elastography before liver resection between 2019 and 2022 were retrospectively evaluated. Clinical data included body mass index (BMI) and laboratory parameters. The histologically determined hepatic fat fraction (HFF) and fibrosis stages were reviewed by pathologists blinded to clinical and radiologic data. The Pearson correlation coefficient between CAP and HFF was calculated. The diagnostic performance of CAP for significant hepatic steatosis (HFF ≥10%) was assessed using areas under the receiver operating curve (AUCs), stratified by fibrosis stages (F0-1 vs. F2-4). Factors significantly associated with CAP were determined by univariable and multivariable linear regression analyses.</p><p><strong>Results: </strong>Among 399 CHB patients (median age 59 years; 306 men), 16.3% showed significant steatosis. HFF ranged from 0% to 60%. Of these patients, 9.8%, 19.8%, 29.3%, and 41.1% had fibrosis stages F0-1, F2, F3, and F4, respectively. CAP positively correlated with HFF (r=0.445, P<0.001). The AUC of CAP for diagnosing significant steatosis was 0.786 (95% confidence interval [CI], 0.726 to 0.845) overall, and significantly lower in F2-4 (0.772; 95% CI, 0.708 to 0.836) than in F0-1 (0.924; 95% CI, 0.835 to 1.000) (P=0.006). Multivariable analysis showed that BMI (P<0.001) and HFF (P<0.001) significantly affected CAP, whereas LSM and fibrosis stages did not.</p><p><strong>Conclusion: </strong>CAP evaluations of significant hepatic steatosis are less reliable in CHB patients with significant or more advanced (F2-4) than with no or mild (F0-1) fibrosis.</p>","PeriodicalId":54227,"journal":{"name":"Ultrasonography","volume":" ","pages":"83-91"},"PeriodicalIF":2.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11717679/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142741241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-10-07DOI: 10.14366/usg.24149
Takayoshi Uematsu
{"title":"Equity in breast cancer screening for Asian women with dense breasts through ultrasonography: lessons learned from Japanese mammography screening and the J-START trial.","authors":"Takayoshi Uematsu","doi":"10.14366/usg.24149","DOIUrl":"10.14366/usg.24149","url":null,"abstract":"","PeriodicalId":54227,"journal":{"name":"Ultrasonography","volume":" ","pages":"42-47"},"PeriodicalIF":2.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11717688/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142741255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-12-02DOI: 10.14366/usg.24168
Seung Hyup Kim
Nutcracker syndrome is caused by the compression of the left renal vein between the abdominal aorta and the superior mesenteric artery. The use of Doppler ultrasonography to diagnose this condition is challenging due to the dynamic nature of the nutcracker phenomenon and the variability of its symptoms, which can fluctuate with changes in patient posture and respiration. This review emphasizes the critical role of Doppler ultrasonography in identifying and managing nutcracker syndrome. It also explores the various subtypes of the nutcracker phenomenon and discusses how Doppler ultrasonography can improve patient outcomes by enabling management strategies that are informed by dynamic assessments of left renal vein compression.
{"title":"The role of Doppler ultrasonography in the detection and management of nutcracker syndrome.","authors":"Seung Hyup Kim","doi":"10.14366/usg.24168","DOIUrl":"10.14366/usg.24168","url":null,"abstract":"<p><p>Nutcracker syndrome is caused by the compression of the left renal vein between the abdominal aorta and the superior mesenteric artery. The use of Doppler ultrasonography to diagnose this condition is challenging due to the dynamic nature of the nutcracker phenomenon and the variability of its symptoms, which can fluctuate with changes in patient posture and respiration. This review emphasizes the critical role of Doppler ultrasonography in identifying and managing nutcracker syndrome. It also explores the various subtypes of the nutcracker phenomenon and discusses how Doppler ultrasonography can improve patient outcomes by enabling management strategies that are informed by dynamic assessments of left renal vein compression.</p>","PeriodicalId":54227,"journal":{"name":"Ultrasonography","volume":" ","pages":"31-41"},"PeriodicalIF":2.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11717685/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142877792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-12-30DOI: 10.14366/usg.24218
Jung-Eun Cheon
{"title":"Recognition and appreciation of our peer reviewers: honoring the 2024 best reviewer awards.","authors":"Jung-Eun Cheon","doi":"10.14366/usg.24218","DOIUrl":"10.14366/usg.24218","url":null,"abstract":"","PeriodicalId":54227,"journal":{"name":"Ultrasonography","volume":"44 1","pages":"3-4"},"PeriodicalIF":2.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11717678/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-09-25DOI: 10.14366/usg.24148
Xin Guan, Hong Han, Huixiong Xu
Lower-extremity vascular disease has a high morbidity rate and often leads to disability and death in its advanced stages. Although angiography-guided endovascular intervention is the primary treatment for peripheral vascular disease, it frequently fails to detect subtle lumen features and falls short of meeting the increasing clinical need for precise management. Intravascular ultrasound (IVUS) merges noninvasive ultrasound imaging with invasive catheterization techniques, providing 360° imaging of the vascular cross-section and delivering accurate information about lesion morphology. IVUS has been crucial in supporting decisionmaking for preoperative assessment, intraoperative monitoring, and postoperative optimization during vascular interventions. This review aims to summarize the latest applications of IVUS in lower-extremity vascular disease, discuss its strengths and limitations, and explore future directions for its use.
{"title":"Cutting-edge progress of intravascular ultrasound in lower-extremity vascular interventions.","authors":"Xin Guan, Hong Han, Huixiong Xu","doi":"10.14366/usg.24148","DOIUrl":"10.14366/usg.24148","url":null,"abstract":"<p><p>Lower-extremity vascular disease has a high morbidity rate and often leads to disability and death in its advanced stages. Although angiography-guided endovascular intervention is the primary treatment for peripheral vascular disease, it frequently fails to detect subtle lumen features and falls short of meeting the increasing clinical need for precise management. Intravascular ultrasound (IVUS) merges noninvasive ultrasound imaging with invasive catheterization techniques, providing 360° imaging of the vascular cross-section and delivering accurate information about lesion morphology. IVUS has been crucial in supporting decisionmaking for preoperative assessment, intraoperative monitoring, and postoperative optimization during vascular interventions. This review aims to summarize the latest applications of IVUS in lower-extremity vascular disease, discuss its strengths and limitations, and explore future directions for its use.</p>","PeriodicalId":54227,"journal":{"name":"Ultrasonography","volume":" ","pages":"5-18"},"PeriodicalIF":2.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11717682/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142669657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: Internal cervical os (ICO) stiffness is related to menstrual pain, a key symptom of endometriosis. The study evaluated whether women with endometriosis have a stiffer ICO than unaffected women.
Methods: A retrospective cross-sectional analysis was conducted using prospectively collected data from women with and without endometriosis, spanning from June 2020 to September 2022. Endometriosis was diagnosed through clinical and ultrasound evaluations, with histological confirmation in a subset of participants. Strain elastography (SE) was employed to measure tissue elasticity in four cervical regions of interest: the ICO and the anterior, posterior, and middle cervical compartments (ACC, PCC, and MCC, respectively). Tissue elasticity was quantified using a color-based scoring system ranging from 0.1 (blue, indicating less elasticity) to 3.0 (red, indicating greater elasticity).
Results: Overall, 287 women were included, with 157 diagnosed with endometriosis and 130 controls. On SE, women with endometriosis exhibited a lower color score (mean±standard deviation), indicating lower elasticity, for the ICO (0.56±0.28 vs. 0.70±0.26, P=0.001) and PCC (0.69±0.30 vs. 0.80±0.27, P=0.002). Additionally, they had a lower ICO/MCC ratio (0.45±0.28 vs. 0.60±0.32, P=0.001) and ICO/ACC ratio (0.68±0.42 vs. 0.85±0.39, P=0.001). Multiple logistic regression analysis revealed that endometriosis was associated with the ICO color score (odds ratio, 0.053; 95% confidence interval, 0.014 to 0.202; R2=0.358; P=0.001), even after adjusting for confounding factors like the presence of myomas (P=0.040) and the use of hormonal therapy (P=0.001). The results were corroborated in women with histologically confirmed endometriosis (n=71).
Conclusion: The findings suggest a potential relationship between a stiffer ICO and endometriosis.
目的:宫颈内口(ICO)僵硬与痛经有关,而痛经是子宫内膜异位症的一个主要症状。该研究评估了患有子宫内膜异位症的女性是否比未受影响的女性宫颈内口更僵硬:研究利用前瞻性收集的2020年6月至2022年9月期间患有和未患有子宫内膜异位症的女性数据进行了回顾性横断面分析。子宫内膜异位症是通过临床和超声波评估确诊的,并在一部分参与者中进行了组织学确认。应变弹性成像(SE)用于测量四个宫颈相关区域的组织弹性:宫颈内口(ICO)和宫颈前、后、中段(分别为 ACC、PCC 和 MCC)。采用基于颜色的评分系统对组织弹性进行量化,评分范围从 0.1(蓝色,表示弹性较小)到 3.0(红色,表示弹性较大):总共有 287 名妇女参加了研究,其中 157 名被诊断为子宫内膜异位症,130 名为对照组。在 SE 中,患有子宫内膜异位症的妇女的 ICO(0.56±0.28 vs. 0.70±0.26,P=0.001)和 PCC(0.69±0.30 vs. 0.80±0.27,P=0.002)的颜色得分(平均值±标准偏差)较低,表明弹性较差。此外,他们的 ICO/MCC 比值(0.45±0.28 vs. 0.60±0.32,P=0.001)和 ICO/ACC 比值(0.68±0.42 vs. 0.85±0.39,P=0.001)也较低。多元逻辑回归分析显示,即使在调整了肌瘤存在(P=0.040)和使用激素治疗(P=0.001)等混杂因素后,子宫内膜异位症与 ICO 颜色评分仍有关联(几率比 0.053;95% 置信区间 0.014 至 0.202;R2=0.358;P=0.001)。经组织学证实患有子宫内膜异位症的妇女(71 人)也证实了这一结果:结论:研究结果表明,较硬的 ICO 与子宫内膜异位症之间存在潜在关系。
{"title":"Relationship between endometriosis and uterine cervical elasticity assessed using ultrasound strain elastography.","authors":"Anjeza Xholli, Filippo Molinari, Umberto Scovazzi, Ambrogio Pietro Londero, Isabella Perugi, Chiara Kratochwila, Francesca Cremonini, Angelo Cagnacci","doi":"10.14366/usg.24117","DOIUrl":"10.14366/usg.24117","url":null,"abstract":"<p><strong>Purpose: </strong>Internal cervical os (ICO) stiffness is related to menstrual pain, a key symptom of endometriosis. The study evaluated whether women with endometriosis have a stiffer ICO than unaffected women.</p><p><strong>Methods: </strong>A retrospective cross-sectional analysis was conducted using prospectively collected data from women with and without endometriosis, spanning from June 2020 to September 2022. Endometriosis was diagnosed through clinical and ultrasound evaluations, with histological confirmation in a subset of participants. Strain elastography (SE) was employed to measure tissue elasticity in four cervical regions of interest: the ICO and the anterior, posterior, and middle cervical compartments (ACC, PCC, and MCC, respectively). Tissue elasticity was quantified using a color-based scoring system ranging from 0.1 (blue, indicating less elasticity) to 3.0 (red, indicating greater elasticity).</p><p><strong>Results: </strong>Overall, 287 women were included, with 157 diagnosed with endometriosis and 130 controls. On SE, women with endometriosis exhibited a lower color score (mean±standard deviation), indicating lower elasticity, for the ICO (0.56±0.28 vs. 0.70±0.26, P=0.001) and PCC (0.69±0.30 vs. 0.80±0.27, P=0.002). Additionally, they had a lower ICO/MCC ratio (0.45±0.28 vs. 0.60±0.32, P=0.001) and ICO/ACC ratio (0.68±0.42 vs. 0.85±0.39, P=0.001). Multiple logistic regression analysis revealed that endometriosis was associated with the ICO color score (odds ratio, 0.053; 95% confidence interval, 0.014 to 0.202; R2=0.358; P=0.001), even after adjusting for confounding factors like the presence of myomas (P=0.040) and the use of hormonal therapy (P=0.001). The results were corroborated in women with histologically confirmed endometriosis (n=71).</p><p><strong>Conclusion: </strong>The findings suggest a potential relationship between a stiffer ICO and endometriosis.</p>","PeriodicalId":54227,"journal":{"name":"Ultrasonography","volume":" ","pages":"490-498"},"PeriodicalIF":2.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11532525/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142382405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}